VDAC2 loss enhances antitumor immune responses to PD-1 blockade in castration-resistant prostate cancer
Year: 2026
Type: preprint
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.7370003
Institution: Tianjin Medical University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7204708002
